Meet the 11 rising stars of longevity medicine

The field of longevity medicine is gaining traction, attracting talented individuals making significant strides in research and technology. Among these pioneers is a notable investor in cutting-edge longevity science, who co-founded LongeVC and AniVC, focusing on evidence-based advancements. Insilico Medicine’s founder and CEO has been recognized for his innovative use of AI technologies in developing longevity drugs. Meanwhile, Dr. Nicole Sirotin is leading the world’s first licensed healthy longevity medicine clinic, situated in Abu Dhabi. A passionate advocate for equal access to longevity treatments, the founder of the Alliance for Longevity Initiatives (A4LI) is making waves in the advocacy space. At Altos Labs, a vice president is developing AI models that could potentially improve or even reverse aging processes. Bridging the gap between laboratory research and clinical practice is crucial. A professor at the Mayo Clinic is taking significant steps to ensure that cutting-edge longevity research is applied to patient care effectively. The executive director of XPRIZE Healthspan is also at the forefront, driving innovative research in longevity. Some of the most exciting developments include a founder and CEO who leads efforts to create an FDA-approved longevity drug, and another co-founder who is investigating ways to extend healthy lifespans to around 120 years. A president of the Healthy Longevity Medicine Society is pushing for evidence-based tests and treatments, while an associate professor at Columbia University is exploring ways to measure aging speed and identify methods to slow it down. The longevity industry is projected to balloon to $8 trillion by 2030, a significant increase from $5.3 billion in 2023, according to UBS analysts. The emphasis on healthy living is becoming as vital as disease treatment, with innovative ideas being recognized as the key to transformative change in this expanding field. Business Insider is proud to announce its inaugural Rising Stars of Longevity, spotlighting 11 exceptional individuals whose work is set to reshape the future of longevity science and medicine. Expert Andrea Maier stated that these winners are pioneers with a profound understanding of aging biology, committed to enhancing patient outcomes. Among the Rising Stars, Daniel Belsky is exploring the effects of common prescription drugs on aging, with ambitions to develop new gerotherapeutics to extend healthspan. Dr. Evelyne Bischof is revolutionizing patient care with her extensive, personalized health assessments. Peter Fedichev aims to apply physics to biology to understand aging mechanisms and develop anti-aging drugs. Celine Halioua is working on longevity drugs for dogs, with hopes of applying the findings to human medicine. Jamie Justice is leading a competition focused on extending healthy lifespans, while Nathan LeBrasseur’s research targets the impacts of aging at the cellular level. Morgan Levine is leveraging AI to create models that could accelerate scientific discoveries in aging. Dylan Livingston founded A4LI to promote policies that enhance longevity access, while Nicole Sirotin has established the first longevity clinic standards in the UAE. Finally, Alex Zhavoronkov’s work with Insilico Medicine highlights the potential of AI in drug development aimed at prolonging life. As these innovators continue to break ground, the future of longevity medicine looks promising, paving the way for healthier, longer lives.